Product Information
CU-CPT-8m is a small molecule that has been shown to inhibit the activation of toll-like receptor 4 (TLR4) and TLR2 in monocytes, glomerular inflammation, and renal inflammation. CU-CPT-8m also inhibits the production of pro-inflammatory cytokines and chemokines, such as IL-1β, IL-6, IL-10, and TNFα. CU-CPT-8m has been shown to be both safe and effective in preclinical models of chronic kidney diseases in animal models. CU-CPT-8m may be a promising new option for the treatment of inflammatory kidney diseases.
Chemical properties
Technical inquiry about: 3D-AFA07983 CU-CPT-8m
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
